The worldwide costs of dementia in 2019

A Wimo, K Seeher, R Cataldi, E Cyhlarova… - Alzheimer's & …, 2023 - Wiley Online Library
Introduction Dementia is a leading cause of death and disability globally. Estimating total
societal costs demonstrates the wide impact of dementia and its main direct and indirect …

[HTML][HTML] Hormone replacement therapy is associated with improved cognition and larger brain volumes in at-risk APOE4 women: results from the European …

RNM Saleh, M Hornberger, CW Ritchie… - Alzheimer's research & …, 2023 - Springer
Background The risk of dementia is higher in women than men. The metabolic
consequences of estrogen decline during menopause accelerate neuropathology in …

Neurogenesis in aging and age-related neurodegenerative diseases

L Culig, X Chu, VA Bohr - Ageing research reviews, 2022 - Elsevier
Adult neurogenesis, the process by which neurons are generated in certain areas of the
adult brain, declines in an age-dependent manner and is one potential target for extending …

Physical activity for cognitive health promotion: An overview of the underlying neurobiological mechanisms

C Chen, S Nakagawa - Ageing Research Reviews, 2023 - Elsevier
Physical activity is one of the modifiable factors of cognitive decline and dementia with the
strongest evidence. Although many influential reviews have illustrated the neurobiological …

Association of the mediterranean dietary approaches to stop hypertension intervention for neurodegenerative delay (MIND) diet with the risk of dementia

H Chen, K Dhana, Y Huang, L Huang, Y Tao… - JAMA …, 2023 - jamanetwork.com
Importance Dementia threatens the well-being of older adults, making efforts toward
prevention of great importance. Objective To evaluate the association of the Mediterranean …

MAFLD: A multisystem disease

RM Pipitone, C Ciccioli, G Infantino… - Therapeutic …, 2023 - journals.sagepub.com
Nonalcoholic fatty liver disease (NAFLD), affecting about 25% of general population and
more than 50% of dysmetabolic patients, is an emerging cause of chronic liver disease and …

[HTML][HTML] A two-step workflow based on plasma p-tau217 to screen for amyloid β positivity with further confirmatory testing only in uncertain cases

WS Brum, NC Cullen, S Janelidze, NJ Ashton… - Nature Aging, 2023 - nature.com
Cost-effective strategies for identifying amyloid-β (Aβ) positivity in patients with cognitive
impairment are urgently needed with recent approvals of anti-Aβ immunotherapies for …

[HTML][HTML] Global and regional spending on dementia care from 2000–2019 and expected future health spending scenarios from 2020–2050: an economic modelling …

P Pedroza, MK Miller-Petrie, C Chen… - …, 2022 - thelancet.com
Background The global burden of dementia is increasing. As diagnosis and treatment rates
increase and populations grow and age, additional diagnosed cases will present a …

Advancing cell therapy for neurodegenerative diseases

S Temple - Cell Stem Cell, 2023 - cell.com
Cell-based therapies are being developed for various neurodegenerative diseases that
affect the central nervous system (CNS). Concomitantly, the roles of individual cell types in …

Amyloid-related imaging abnormalities (ARIA): radiological, biological and clinical characteristics

H Hampel, A Elhage, M Cho, LG Apostolova… - Brain, 2023 - academic.oup.com
Excess accumulation and aggregation of toxic soluble and insoluble amyloid-β species in
the brain are a major hallmark of Alzheimer's disease. Randomized clinical trials show …